|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
4.51/14.80
|
Enterprise Value
83.12B
|
Balance Sheet |
Book Value Per Share
88.75
|
Cash Flow |
Cash Flow Yield
0.05
|
Income Statement |
Total Revenue
19.37B
|
Operating Revenue Per Share
65.90
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/19 16:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business. |